Prophylactic measure against reactivation of hepatitis B virus in chemotherapy for gastrointestinal cancer

被引：0
|
作者：
Tsushima, Takahiro [1 ]
机构：
[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD4-3
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [31] Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
    Chun-Jen Liu
    Pei-Jer Chen
    Ding-Shinn Chen
    Jia-Horng Kao
    Hepatology International, 2013, 7 : 316 - 326
  • [32] Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
    Yeo, W
    Ho, WM
    Hui, P
    Chan, PKS
    Lam, KC
    Lee, JJ
    Johnson, PJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (03) : 209 - 215
  • [33] Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
    Yeo, W
    Chan, PKS
    Hui, P
    Ho, WM
    Lam, KC
    Kwan, WH
    Zhong, S
    Johnson, PJ
    JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (04) : 553 - 561
  • [34] Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: Role of lamivudine prophylaxis
    Coiffier, Bertrand
    CANCER INVESTIGATION, 2006, 24 (05) : 548 - 552
  • [35] Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate
    Yamauchi, Ryo
    Takeyama, Yasuaki
    Takata, Kazuhide
    Fukunaga, Atsushi
    Sakurai, Kunitoshi
    Tanaka, Takashi
    Fukuda, Hiromi
    Fukuda, Sho
    Kunimoto, Hideo
    Umeda, Kaoru
    Morihara, Daisuke
    Yokoyama, Keiji
    Irie, Makoto
    Shakado, Satoshi
    Sakisaka, Shotaro
    Hirai, Fumihito
    INTERNAL MEDICINE, 2020, 59 (09) : 1163 - 1166
  • [36] Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
    Liu, Chun-Jen
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 316 - 326
  • [37] Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy
    Wani, Manzoor A.
    Sodhi, Jaswinder S.
    Yatoo, Ghulam N.
    Shah, Altaf
    Geelani, Sajad
    Zargar, Showkat A.
    Gulzar, Ghulam M.
    Khan, Mushtaq
    Aziz, Sheikh A.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (06) : 590 - 598
  • [38] Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
    Keam, Bhumsuk
    Lee, Jeong-Hoon
    Im, Seock-Ah
    Yoon, Jung-Hwan
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (05): : 465 - 477
  • [39] Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy
    Yin-Hua Wang
    Lei Fan
    Li Wang
    Run Zhang
    Ji Xu
    Cheng Fang
    Jian-Yong Li
    Wei Xu
    Supportive Care in Cancer, 2013, 21 : 1265 - 1271
  • [40] Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy
    Wang, Yin-Hua
    Fan, Lei
    Wang, Li
    Zhang, Run
    Xu, Ji
    Fang, Cheng
    Li, Jian-Yong
    Xu, Wei
    SUPPORTIVE CARE IN CANCER, 2013, 21 (05) : 1265 - 1271
12345